Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell Lines01:16

Cell Lines

7.7K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
7.7K
Variability: Analysis01:11

Variability: Analysis

169
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
169
Cell Culture01:21

Cell Culture

17.7K
Most vertebrate cells grow in vitro attached to a substrate as a monolayer, called adherent cultures. The flasks and plates used to grow cells are chemically treated to facilitate cell attachment. However, a few cell types, such as hematopoietic cells, can grow in a suspension. In contrast to adherent cultures, suspension cultures can grow in non-treated cultureware using magnetic stirrers or spinner flasks to agitate the culture media
17.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia.

Molecular cancer·2026
Same author

On the state of protein function prediction: a report on the fourth CAFA challenge.

bioRxiv : the preprint server for biology·2026
Same author

AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia.

Research square·2026
Same author

Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative properties.

Cell death discovery·2026
Same author

Outcomes for Sinonasal Undifferentiated Carcinoma (SNUC): An International Multi-Center Retrospective Cohort Study.

Cancers·2026
Same author

Placental crises: disruptive selection and maternal under-investment as the foundations of mammalian placental evolution and dysfunction.

Biological reviews of the Cambridge Philosophical Society·2026

Related Experiment Video

Updated: Aug 13, 2025

Enhanced Reproducibility and Precision of High-Throughput Quantification of Bacterial Growth Data Using a Microplate Reader
09:15

Enhanced Reproducibility and Precision of High-Throughput Quantification of Bacterial Growth Data Using a Microplate Reader

Published on: July 27, 2022

2.1K

Large inherent variability in data derived from highly standardised cell culture experiments.

Ian G Reddin1, Tim R Fenton1, Mark N Wass2

  • 1School of Biosciences, University of Kent, Canterbury, UK; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Pharmacological Research
|January 21, 2023
PubMed
Summary

Preclinical cancer drug testing shows high variability, even with standardized methods. This inherent data inconsistency impacts drug development and requires further research into more robust model systems.

Keywords:
Anti-cancer drugsAttritionCancer cell lineChemotherapyData reproducibilityDrug developmentDrug discoveryNCI60ReplicabilityScreen

More Related Videos

Designing Automated, High-throughput, Continuous Cell Growth Experiments Using eVOLVER
07:26

Designing Automated, High-throughput, Continuous Cell Growth Experiments Using eVOLVER

Published on: May 19, 2019

12.1K
Temporal Quantification of MAPK Induced Expression in Single Yeast Cells
07:59

Temporal Quantification of MAPK Induced Expression in Single Yeast Cells

Published on: October 4, 2013

8.6K

Related Experiment Videos

Last Updated: Aug 13, 2025

Enhanced Reproducibility and Precision of High-Throughput Quantification of Bacterial Growth Data Using a Microplate Reader
09:15

Enhanced Reproducibility and Precision of High-Throughput Quantification of Bacterial Growth Data Using a Microplate Reader

Published on: July 27, 2022

2.1K
Designing Automated, High-throughput, Continuous Cell Growth Experiments Using eVOLVER
07:26

Designing Automated, High-throughput, Continuous Cell Growth Experiments Using eVOLVER

Published on: May 19, 2019

12.1K
Temporal Quantification of MAPK Induced Expression in Single Yeast Cells
07:59

Temporal Quantification of MAPK Induced Expression in Single Yeast Cells

Published on: October 4, 2013

8.6K

Area of Science:

  • Oncology
  • Pharmacology
  • Biostatistics

Background:

  • High clinical attrition rates in cancer drug development are linked to poor preclinical model predictivity and limited replicability.
  • The actual achievable level of replicability in preclinical cancer drug testing remains largely unknown.

Purpose of the Study:

  • To analyze the NCI60 cancer cell line screen data, the largest known repository of repeated experiments, to quantify intra-laboratory variability.
  • To determine the technically feasible level of replicability in anti-cancer drug testing.

Main Methods:

  • Analysis of 2.8 million experiments from the NCI60 cancer cell line screen, spanning decades.
  • Statistical evaluation of data variability, including GI50 fold changes, across numerous biological replicates.
  • Assessment of variability after outlier removal and under controlled experimental conditions.

Main Results:

  • Profound intra-laboratory data variability was observed, even with highly standardized protocols.
  • 70.5% of compound/cell line combinations with over 100 replicates showed maximum GI50 fold changes exceeding 1000.
  • Significant variability persisted across FDA-approved drugs, experimental agents, and after data quality control measures.

Conclusions:

  • High variability is an intrinsic characteristic of anti-cancer drug testing, irrespective of standardized protocols.
  • Awareness of this inherent variability is crucial for realistic data interpretation in drug development.
  • Future research should explore diverse model systems, including animal and patient-derived models, to enhance data robustness.